Medical information Clinical review pending

Genetic Testing

Hains Mycobacterium Tuberculosis First Second Line Drug Resistance Profile Test

This test identifies resistance to first and second-line anti-TB drugs in Mycobacterium tuberculosis, guiding effective treatment for tuberculosis patients in Kenya.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: 3 mL (2 mL minimum) of sputum, bronchoalveolar lavage fluid, bronchial aspirate, or cultured growth on appropriate media. Sample must be collected in a sterile, screw-capped container.
Results: Results are typically available by Friday for samples submitted by 11 AM. Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required. Ensure the sample is collected according to standard laboratory procedures.

Test priceKSh 14,040

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Hains Mycobacterium Tuberculosis First Second Line Drug Resistance Profile Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected tuberculosis (TB) infection.
✓Symptoms of TB (persistent cough, fever, night sweats, weight loss).
✓History of previous TB treatment.
✓Suspected treatment failure for TB.
✓Exposure to individuals with drug-resistant TB.
✓Need for guidance on appropriate anti-TB therapy.

In plain language

What this test helps you understand

This test helps determine the specific anti-TB drugs to which a patient's tuberculosis strain is resistant. This information is critical for selecting an effective treatment regimen, especially in cases of suspected or confirmed drug resistance, thereby improving patient outcomes and reducing transmission.

The Hains Mycobacterium Tuberculosis First Second Line Drug Resistance Profile Test is a vital diagnostic tool for managing tuberculosis (TB). It identifies resistance to both first-line and second-line anti-TB medications, helping healthcare providers select the most effective treatment plan. This is particularly important in Kenya where TB remains a significant health concern. The test uses advanced molecular methods to provide rapid and accurate results. It is recommended for individuals with symptoms suggestive of TB, those with a history of TB treatment failure, or those exposed to drug-resistant TB strains. Understanding drug resistance is crucial for successful treatment and preventing the spread of TB.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. Ensure the sample is collected according to standard laboratory procedures.

Sample3 mL (2 mL minimum) of sputum, bronchoalveolar lavage fluid, bronchial aspirate, or cultured growth on appropriate media. Sample must be collected in a sterile, screw-capped container.

MethodologyMolecular diagnostics, including PCR and line probe assays, are used to detect genetic mutations associated with resistance to anti-TB drugs.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects resistance to specific drugs included in the panel. It may not detect resistance to all possible anti-TB drugs. Results should be interpreted in conjunction with clinical findings and other laboratory data. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Tuberculosis is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis, which typically affects the lungs but can also affect other parts of the body.

This test identifies which anti-TB drugs are ineffective against a specific strain of TB, allowing doctors to choose the right medication from the start, improving treatment success.

A sample of sputum (phlegm), or other respiratory samples like bronchoalveolar lavage fluid or bronchial aspirate, is required.

Results are generally available by Friday for samples received by 11 AM. Please confirm the current turnaround time with the laboratory.

Drug resistance means the bacteria causing TB are no longer killed by the antibiotic drugs normally used to treat the infection.

We have branches in Nairobi, Mombasa, and Kisumu. You can contact us to book your test.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp